Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Rockville, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global post herpetic neuralgia treatment market is calculated to reach a size of US$ 822.4 million in 2024 and climb to US$ 1.38 billion by the ...

Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send the pain signals like other analgesics, this ...

A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

The future outlook for pain relief appears promising as new trends point toward a move to better whole-person care that's ...

Learn more about common anesthesia medicines bupivacaine and lidocaine, including their benefits, risks, differences, and ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

Your next vacation may be a sprint or a marathon, but either way it’s likely to be tough on your feet. Between the airport ...